Cargando...

Beyond Access vs. Protection in Trials of Innovative Therapies

Review of first-in-human trials should aim to safeguard the integrity of the scientific enterprise through a focus on pre-clinical and clinical study quality.

Guardado en:
Detalles Bibliográficos
Publicado en:Science
Autores principales: London, Alex John, Kimmelman, Jonathan, Emborg, Marina Elena
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4516403/
https://ncbi.nlm.nih.gov/pubmed/20466907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.1189369
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!